136 related articles for article (PubMed ID: 31512022)
1. New Perspective Enteric-Coated Tablet Dosage Form for Oral Administration of Ceftriaxone: In Vitro and In Vivo Assessments.
Maghrabia AE; Boughdady MF; Meshali MM
AAPS PharmSciTech; 2019 Sep; 20(7):306. PubMed ID: 31512022
[TBL] [Abstract][Full Text] [Related]
2. Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.
Maghrabia A; Boughdady M; Meshali M
Int J Nanomedicine; 2021; 16():5937-5953. PubMed ID: 34511899
[TBL] [Abstract][Full Text] [Related]
3. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
4. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex.
Miyazaki Y; Tanaka Y; Yakou S; Takayama K
J Control Release; 2006 Aug; 114(1):47-52. PubMed ID: 16824636
[TBL] [Abstract][Full Text] [Related]
5. Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation.
Debunne A; Vervaet C; Mangelings D; Remon JP
Eur J Pharm Sci; 2004 Jul; 22(4):305-14. PubMed ID: 15196587
[TBL] [Abstract][Full Text] [Related]
6. Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability.
Kim JS; Jang SW; Son M; Kim BM; Kang MJ
Eur J Pharm Sci; 2016 Jan; 82():45-51. PubMed ID: 26594027
[TBL] [Abstract][Full Text] [Related]
7. A new dual function orodissolvable/dispersible meclizine HCL tablet to challenge patient inconvenience: in vitro evaluation and in vivo assessment in human volunteers.
Darwesh AY; El-Dahhan MS; Meshali MM
Drug Deliv Transl Res; 2021 Oct; 11(5):2209-2223. PubMed ID: 33443718
[TBL] [Abstract][Full Text] [Related]
8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
9. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
Chen J; Huang GD; Tan SR; Guo J; Su ZQ
Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
[TBL] [Abstract][Full Text] [Related]
10. Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon.
Nykänen P; Lempää S; Aaltonen ML; Jürjenson H; Veski P; Marvola M
Int J Pharm; 2001 Oct; 229(1-2):155-62. PubMed ID: 11604268
[TBL] [Abstract][Full Text] [Related]
11. A two pulse drug delivery system for amoxicillin: an attempt to counter the scourge of bacterial resistance against antibiotics.
Akhter H; Saigal N; Baboota S; Faisal S; Ali J
Acta Pharm; 2011 Sep; 61(3):313-22. PubMed ID: 21945910
[TBL] [Abstract][Full Text] [Related]
12. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
[TBL] [Abstract][Full Text] [Related]
13. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
14. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets.
Zhang Y; Wo SK; Leng W; Gao F; Yan X; Zuo Z
J Control Release; 2022 Jun; 346():275-288. PubMed ID: 35461968
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.
Drechsler M; Garbacz G; Thomann R; Schubert R
Eur J Pharm Biopharm; 2014 Nov; 88(3):807-15. PubMed ID: 25301294
[TBL] [Abstract][Full Text] [Related]
17. Enteric-coated tablets improve oral bioavailability of DX-9065, a novel anticoagulant.
Fujii Y; Kanamaru T; Kikuchi H; Yamashita S; Sakuma S
Eur J Pharm Sci; 2011 Mar; 42(4):392-9. PubMed ID: 21238588
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor.
Wong CY; Martinez J; Carnagarin R; Dass CR
J Pharm Pharmacol; 2017 Mar; 69(3):285-294. PubMed ID: 28155991
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
Sinha VR; Mittal BR; Kumria R
Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
[TBL] [Abstract][Full Text] [Related]
20. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
Nath B; Nath LK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
